Old Web
English
Sign In
Acemap
>
Paper
>
Safety and Efficacy of BAY 1817080, a P2X3 Receptor Antagonist, in Patients with Refractory Chronic Cough (RCC)
Safety and Efficacy of BAY 1817080, a P2X3 Receptor Antagonist, in Patients with Refractory Chronic Cough (RCC)
2020
Alyn H. Morice
Jaclyn A. Smith
Lorcan McGarvey
Surinder S. Birring
S.M. Parker
A. Turner
Isabella Gashaw
L. Fels
Stefan Klein
K. Francke
Christian Friedrich
Keywords:
Bay
Chronic cough
Gastroenterology
P2X3 Receptor
in patient
Refractory
Medicine
Antagonist
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
6
Citations
NaN
KQI
[]